Inbrain Pharma

InBrain Pharma is a biotechnology company specializing in brain infusion drugs for the management of neurological disorders. InBrain Pharma’s approach is unique and groundbreaking in treating advanced Parkinson’s disease, providing continuous dopaminergic stimulation in the brains of patients experiencing severe and refractory motor complications associated with L-dopa oral therapy. This pharmacological modulation of dopamine neurotransmission is achieved through continuous, titrated intracerebroventricular (i.c.v.) dopamine administration. This novel therapeutic modality ushers in the era of precision medicine in the management of neurodegenerative diseases.